Pub Date : 2025-06-19DOI: 10.1016/j.abrep.2025.100623
Gianluca Lo Coco , Rachel F. Rodgers
Previous evidence supports the existence of a relationship between greater use of highly visual social media and heightened body image and eating concerns. However, to date, the role of problematic social network use has not been articulated in relation to these outcomes and the multiple dynamics underlying these associations need to be further conceptualized. Moreover, models of the exacerbation and maintenance of these body image concerns are lacking, and little attention has been paid to state-level predictors and maintenance factors. The aim of this position paper is to propose model of the maintenance and exacerbation of body image and eating concerns in the context of problematic social network use. Specifically, it is suggested that body image and eating concerns are associated with both generalized and specific problematic social network use through appearance-motivated use of social networks (appearance improvement seeking information, suggested/recommended appearance content engagement, and homogeneous social media experience), as well as appearance-centered online interactions (selfie behaviors, appearance feedback, and compulsive social network checking), leading to state negative affect and internalization of appearance ideals. In addition, four factors are proposed as risk (appearance feedback sensitivity, and social network rumination) and protective (social media literacy and positive body image) factors, respectively. The existing evidence supporting this model as well as future research directions are discussed.
{"title":"A proposed model of the maintenance and exacerbation of body image and eating concerns in the context of problematic social network use","authors":"Gianluca Lo Coco , Rachel F. Rodgers","doi":"10.1016/j.abrep.2025.100623","DOIUrl":"10.1016/j.abrep.2025.100623","url":null,"abstract":"<div><div>Previous evidence supports the existence of a relationship between greater use of highly visual social media and heightened body image and eating concerns. However, to date, the role of problematic social network use has not been articulated in relation to these outcomes and the multiple dynamics underlying these associations need to be further conceptualized. Moreover, models of the exacerbation and maintenance of these body image concerns are lacking, and little attention has been paid to state-level predictors and maintenance factors. The aim of this position paper is to propose model of the maintenance and exacerbation of body image and eating concerns in the context of problematic social network use. Specifically, it is suggested that body image and eating concerns are associated with both generalized and specific problematic social network use through appearance-motivated use of social networks (appearance improvement seeking information, suggested/recommended appearance content engagement, and homogeneous social media experience), as well as appearance-centered online interactions (selfie behaviors, appearance feedback, and compulsive social network checking), leading to state negative affect and internalization of appearance ideals. In addition, four factors are proposed as risk (appearance feedback sensitivity, and social network rumination) and protective (social media literacy and positive body image) factors, respectively. The existing evidence supporting this model as well as future research directions are discussed.</div></div>","PeriodicalId":38040,"journal":{"name":"Addictive Behaviors Reports","volume":"22 ","pages":"Article 100623"},"PeriodicalIF":0.0,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144366161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-17DOI: 10.1016/j.abrep.2025.100622
Maxwell Klapow , Misha Seeff , Maya Adam , Merlin Greuel , Daniel Hoffman , Jessica R. Rogge , Andrew Gordon , Till Bärnighausen , Doron Amsalem
<div><h3>Background and aims</h3><div>Public stigma towards people with addiction negatively impacts help-seeking, treatment and recovery. This pilot study tested the feasibility of conducting a large-scale, online trial to measure the effect of a short, animated storytelling (SAS) stigma reduction video, with and without soundtrack, on addiction stigma, optimism, warmth towards people with addiction, and hopefulness at two timepoints (immediately post-exposure and 14 days later).</div></div><div><h3>Design</h3><div>We used a parallel group, three-arm randomized controlled trial (RCT).</div></div><div><h3>Setting</h3><div>We conducted this fully online study on the Prolific Academic research platform (participant recruitment) and the Qualtrics survey platform (data collection).</div></div><div><h3>Participants</h3><div>We recruited 631 English-speaking adult participants, aged 18–49, residing in the United States.</div></div><div><h3>Interventions</h3><div>Intervention group A received the SAS video intervention. Intervention group B group received the SAS video intervention without sound. The control group received written information about global addiction prevalence, estimated to be time-equivalent with the video interventions.</div></div><div><h3>Measurements</h3><div>We measured participant retention rate at the two-week follow-up to determine the feasibility of conducting the definitive trial. Our co-primary outcomes were addiction stigma, optimism, warmth towards people with addiction and hopefulness, measured using an abbreviated 18-item version of the Attribution Questionnaire (AQ-18), the Brief García’s Interactive Optimism Scale (BIOS-G), a stigma thermometer and a visual analogue scale (VAS). We used repeated-measures ANOVA to assess group-by-time interactions and compared changes from baseline to post-intervention. Participants completed follow-up surveys 14 days post-intervention.</div></div><div><h3>Findings</h3><div>The retention rate from baseline to follow-up was 88.0 %. Exposure to both the video with sound and without sound resulted in significant positive changes compared to the control group, for pity [F (4,1046) = 3.26, η<sup>2</sup> = 0.012, p = 0.011], willingness to help [F (4,1046) = 8.48, η<sup>2</sup> = 0.031, p < 0.001], dangerousness [F (4,1046) = 2.95, η<sup>2</sup> = 0.011, p = 0.019], avoidance [F (4,1046) = 4.25, η<sup>2</sup> = 0.016, p = 0.002], as well as optimism [F (2,595) = 7.7, η<sup>2</sup> = 0.014, p < 0.001], warmth toward people with addiction [F (2,594) = 6.5, η<sup>2</sup> = 0.014, p = 0.002], and hopefulness [F (2,594) = 5.4, η<sup>2</sup> = 0.013, p = 0.005]. No effects were observed for fear or blame stigma sub-scales. These effects were no longer visible at follow-up in this pilot sample. No significant differences were observed between the video with sound and the video without sound.</div></div><div><h3>Conclusions</h3><div>This pilot study demonstrates the feasibility of proceeding with
{"title":"A short, animated storytelling video to reduce addiction stigma: A pilot randomized controlled trial","authors":"Maxwell Klapow , Misha Seeff , Maya Adam , Merlin Greuel , Daniel Hoffman , Jessica R. Rogge , Andrew Gordon , Till Bärnighausen , Doron Amsalem","doi":"10.1016/j.abrep.2025.100622","DOIUrl":"10.1016/j.abrep.2025.100622","url":null,"abstract":"<div><h3>Background and aims</h3><div>Public stigma towards people with addiction negatively impacts help-seeking, treatment and recovery. This pilot study tested the feasibility of conducting a large-scale, online trial to measure the effect of a short, animated storytelling (SAS) stigma reduction video, with and without soundtrack, on addiction stigma, optimism, warmth towards people with addiction, and hopefulness at two timepoints (immediately post-exposure and 14 days later).</div></div><div><h3>Design</h3><div>We used a parallel group, three-arm randomized controlled trial (RCT).</div></div><div><h3>Setting</h3><div>We conducted this fully online study on the Prolific Academic research platform (participant recruitment) and the Qualtrics survey platform (data collection).</div></div><div><h3>Participants</h3><div>We recruited 631 English-speaking adult participants, aged 18–49, residing in the United States.</div></div><div><h3>Interventions</h3><div>Intervention group A received the SAS video intervention. Intervention group B group received the SAS video intervention without sound. The control group received written information about global addiction prevalence, estimated to be time-equivalent with the video interventions.</div></div><div><h3>Measurements</h3><div>We measured participant retention rate at the two-week follow-up to determine the feasibility of conducting the definitive trial. Our co-primary outcomes were addiction stigma, optimism, warmth towards people with addiction and hopefulness, measured using an abbreviated 18-item version of the Attribution Questionnaire (AQ-18), the Brief García’s Interactive Optimism Scale (BIOS-G), a stigma thermometer and a visual analogue scale (VAS). We used repeated-measures ANOVA to assess group-by-time interactions and compared changes from baseline to post-intervention. Participants completed follow-up surveys 14 days post-intervention.</div></div><div><h3>Findings</h3><div>The retention rate from baseline to follow-up was 88.0 %. Exposure to both the video with sound and without sound resulted in significant positive changes compared to the control group, for pity [F (4,1046) = 3.26, η<sup>2</sup> = 0.012, p = 0.011], willingness to help [F (4,1046) = 8.48, η<sup>2</sup> = 0.031, p < 0.001], dangerousness [F (4,1046) = 2.95, η<sup>2</sup> = 0.011, p = 0.019], avoidance [F (4,1046) = 4.25, η<sup>2</sup> = 0.016, p = 0.002], as well as optimism [F (2,595) = 7.7, η<sup>2</sup> = 0.014, p < 0.001], warmth toward people with addiction [F (2,594) = 6.5, η<sup>2</sup> = 0.014, p = 0.002], and hopefulness [F (2,594) = 5.4, η<sup>2</sup> = 0.013, p = 0.005]. No effects were observed for fear or blame stigma sub-scales. These effects were no longer visible at follow-up in this pilot sample. No significant differences were observed between the video with sound and the video without sound.</div></div><div><h3>Conclusions</h3><div>This pilot study demonstrates the feasibility of proceeding with","PeriodicalId":38040,"journal":{"name":"Addictive Behaviors Reports","volume":"22 ","pages":"Article 100622"},"PeriodicalIF":0.0,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144313599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-12DOI: 10.1016/j.abrep.2025.100621
Brian Young , Lorey Wheeler , Hongying Daisy Dai
Purpose
Family environment plays an essential role in youth development. This study sought to examine the intersection effects of parental disapproval and parent–child warm relationships on youth cannabis use behaviors.
Methods
Data were drawn from the youth sample of the 2022 National Survey on Drug Use and Health (NSDUH) study. Multivariable hierarchical models were performed to examine the associations of parental disapproval of offspring’s cannabis use and youth current (past 30-day) cannabis use and past-year DSM-5 cannabis use disorder (CUD), incrementally adjusting for sociodemographic factors, youth substance use behaviors, and family/environment influences.
Results
Among a nationally representative sample of 11,969 youths aged 12–17 years old, 6.0 % reported current cannabis use and 5.2 % reported past-year CUD. Parental disapproval of youth cannabis use differed by parental warmth, age, sex, and race/ethnicity, and it was a strong protective factor against both current cannabis use (AOR[95 % CI] = 0.26[0.18–0.37]) and past-year CUD (AOR[95 % CI] = 0.30[0.20–0.44]) in the fully adjusted models. In addition, reporting their parent as being “warm” all the time (vs. seldom/never), and perceiving harmfulness of cannabis use (high vs. low) were associated with lower odds of youth cannabis use, while being non-Hispanic Black (vs. White), older (vs. younger), using tobacco or alcohol currently, and having peers who use cannabis were associated with higher odds of cannabis use.
Conclusions and relevance
Parental disproval in a warm family environment is protective of youth against cannabis use. Multifaceted interventions involving parents and youth, as well as parental knowledge of the harmfulness of cannabis use, might lessen the impact of youth cannabis use.
{"title":"Parental influence on youth cannabis use: The interplay between disapproval and warmth","authors":"Brian Young , Lorey Wheeler , Hongying Daisy Dai","doi":"10.1016/j.abrep.2025.100621","DOIUrl":"10.1016/j.abrep.2025.100621","url":null,"abstract":"<div><h3>Purpose</h3><div> <!-->Family environment plays an essential role in youth development. This study sought to examine the intersection effects of parental disapproval and parent–child warm relationships on youth cannabis use behaviors.</div></div><div><h3>Methods</h3><div>Data were drawn from the youth sample of the 2022 National Survey on Drug Use and Health (NSDUH) study. Multivariable hierarchical models were performed to examine the associations of parental disapproval of offspring’s cannabis use and youth current (past 30-day) cannabis use and past-year DSM-5 cannabis use disorder (CUD), incrementally adjusting for sociodemographic factors, youth substance use behaviors, and family/environment influences.</div></div><div><h3>Results</h3><div>Among a nationally representative sample of 11,969 youths aged 12–17 years old, 6.0 % reported current cannabis use and 5.2 % reported past-year CUD. Parental disapproval of youth cannabis use differed by parental warmth, age, sex, and race/ethnicity, and it was a strong protective factor against both current cannabis use (AOR[95 % CI] = 0.26[0.18–0.37]) and past-year CUD (AOR[95 % CI] = 0.30[0.20–0.44]) in the fully adjusted models. In addition, reporting their parent as being “warm” all the time (vs. seldom/never), and perceiving harmfulness of cannabis use (high vs. low) were associated with lower odds of youth cannabis use, while being non-Hispanic Black (vs. White), older (vs. younger), using tobacco or alcohol currently, and having peers who use cannabis were associated with higher odds of cannabis use.</div></div><div><h3>Conclusions and relevance</h3><div>Parental disproval in a warm family environment is protective of youth against cannabis use. Multifaceted interventions involving parents and youth, as well as parental knowledge of the harmfulness of cannabis use, might lessen the impact of youth cannabis use.</div></div>","PeriodicalId":38040,"journal":{"name":"Addictive Behaviors Reports","volume":"22 ","pages":"Article 100621"},"PeriodicalIF":0.0,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144366099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-06DOI: 10.1016/j.abrep.2025.100620
Elisa F. Stern , Jarrod M. Ellingson , Jonathan D. Schaefer , Jesse D. Hinckley , Michael C. Stallings , Robin P. Corley , Christian Hopfer , Tamara L. Wall , Soo Hyun Rhee
Purpose
Cannabis use is associated with increased risk for suicidality. However, the directionality of this association and the role of shared familial influences—such as genetics and environment—remains uncertain. Further, despite higher rates of cannabis use and suicidality endorsement in clinical samples, research in these populations is limited. This study examines cross-sectional and prospective associations between cannabis use and suicidality in a sample characterized by earlier cannabis initiation and heavier use than typically reported, while accounting for shared familial influences.
Method
Adolescent sibling groups were recruited from Denver and San Diego (N = 1,261); at least one sibling was recruited from a substance use treatment program, alternative school, or juvenile probation. Participants completed clinical interviews assessing substance use and suicidality at three waves (2001-–2019). Cannabis use frequency was examined as a predictor of suicidality using multilevel models accounting for shared familial influences and within-family clustering. Covariates included alcohol, tobacco, other substance use, age, and sex. Reverse associations and exploratory models assessing tobacco as a predictor were also examined.
Results
Cannabis use was not associated with suicidality (all p’s > 0.05). Exploratory analyses suggested a possible association between tobacco and suicidality (e.g., Wave 1 within-family effect: OR = 1.037, p = 0.016), though these associations were largely reduced to non-significance after accounting for other substance use.
Conclusions
Findings in this high-risk clinical sample are inconsistent with literature linking cannabis use to suicidality in community samples. Results underscore the need for further research on the association between general and polysubstance use risk and suicidality.
目的:大麻的使用与自杀风险的增加有关。然而,这种关联的方向性和共同的家庭影响(如遗传和环境)的作用仍然不确定。此外,尽管临床样本中大麻使用率和自杀倾向较高,但对这些人群的研究有限。本研究在一个样本中考察了大麻使用与自杀之间的横断面和前瞻性关联,该样本的特点是比通常报道的更早开始使用大麻和更重的使用大麻,同时考虑了共同的家庭影响。方法从丹佛和圣地亚哥招募青少年兄弟姐妹组(N = 1,261);至少有一个兄弟姐妹是从药物使用治疗项目、替代学校或青少年缓刑中招募的。参与者完成了三次评估药物使用和自杀行为的临床访谈(2001年至2019年)。使用考虑共同家庭影响和家庭内部聚类的多层模型,对大麻使用频率作为自杀预测因子进行了研究。协变量包括酒精、烟草、其他物质使用、年龄和性别。反向关联和评估烟草作为预测因素的探索性模型也进行了检查。结果使用大麻与自杀倾向无关(p 's >;0.05)。探索性分析表明烟草和自杀之间可能存在关联(例如,波1家族内效应:OR = 1.037, p = 0.016),尽管在考虑了其他物质的使用后,这些关联在很大程度上被降低到无显著性。结论:这一高危临床样本的发现与文献中社区样本中大麻使用与自杀的联系不一致。结果强调需要进一步研究一般和多种物质使用风险与自杀之间的关系。
{"title":"Associations between cannabis use frequency and suicidal thoughts and behaviors: A clinical longitudinal sibling study","authors":"Elisa F. Stern , Jarrod M. Ellingson , Jonathan D. Schaefer , Jesse D. Hinckley , Michael C. Stallings , Robin P. Corley , Christian Hopfer , Tamara L. Wall , Soo Hyun Rhee","doi":"10.1016/j.abrep.2025.100620","DOIUrl":"10.1016/j.abrep.2025.100620","url":null,"abstract":"<div><h3>Purpose</h3><div>Cannabis use is associated with increased risk for suicidality. However, the directionality of this association and the role of shared familial influences—such as genetics and environment—remains uncertain. Further, despite higher rates of cannabis use and suicidality endorsement in clinical samples, research in these populations is limited. This study examines cross-sectional and prospective associations between cannabis use and suicidality in a sample characterized by earlier cannabis initiation and heavier use than typically reported, while accounting for shared familial influences.</div></div><div><h3>Method</h3><div>Adolescent sibling groups were recruited from Denver and San Diego (N = 1,261); at least one sibling was recruited from a substance use treatment program, alternative school, or juvenile probation. Participants completed clinical interviews assessing substance use and suicidality at three waves (2001-–2019). Cannabis use frequency was examined as a predictor of suicidality using multilevel models accounting for shared familial influences and within-family clustering. Covariates included alcohol, tobacco, other substance use, age, and sex. Reverse associations and exploratory models assessing tobacco as a predictor were also examined.</div></div><div><h3>Results</h3><div>Cannabis use was not associated with suicidality (all <em>p’s</em> > 0.05). Exploratory analyses suggested a possible association between tobacco and suicidality (e.g., Wave 1 within-family effect: OR = 1.037, <em>p</em> = 0.016), though these associations were largely reduced to non-significance after accounting for other substance use.</div></div><div><h3>Conclusions</h3><div>Findings in this high-risk clinical sample are inconsistent with literature linking cannabis use to suicidality in community samples. Results underscore the need for further research on the association between general and polysubstance use risk and suicidality.</div></div>","PeriodicalId":38040,"journal":{"name":"Addictive Behaviors Reports","volume":"22 ","pages":"Article 100620"},"PeriodicalIF":0.0,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144288809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-06DOI: 10.1016/j.abrep.2025.100619
Alexandria Macmadu , Yu Li , Fiona Bhondoekhan , Chung-Chou H. Chang , Anees Bahji , Stephen Crystal , Kirsha S. Gordon , Robert D. Kerns , Rachel A. Vickers-Smith , E. Jennifer Edelman , Brandon D.L. Marshall
Background
The bidirectional relationships between opioid use and depressive symptom severity among people living with HIV (PLHIV) are poorly understood. We hypothesized that higher opioid use frequency would be associated with greater subsequent depressive symptom severity and that greater depressive symptom severity would be associated with higher subsequent opioid use frequency.
Methods
We analyzed data from the Veterans Aging Cohort Study (VACS) – survey sample, a prospective cohort including PLHIV receiving care at 8 US Veterans Health Administration sites. From 2002 to 2018, we assessed past year opioid use frequency based on self-reported heroin and/or prescription opioid use at study entry and follow-up, as well as depressive symptom severity. Time-lagged, generalized estimating equation models were used to construct estimates of the association between opioid use frequency and subsequent depressive symptom severity, and vice versa, adjusting for key sociodemographic and clinical characteristics.
Results
In final adjusted models that included 2033 PLHIV (98 % male), subsequent depressive symptom severity was greater (adjusted odds ratio [aOR] = 1.44, 95 % CI: 1.22,1.70) for those who used opioids at least monthly compared to those who never used, and the association between these variables appeared to follow a dose–response pattern. Similarly, subsequent opioid use frequency was higher (aOR = 1.38, 95 % CI: 1.17,1.62) for those with moderate depressive symptom severity compared to those with none.
Conclusions
Enhanced access to screening for substance use disorders, harm reduction services, and medications for opioid use disorder may be warranted in settings that serve veteran PLHIV; strategies expanding access to mental health services may also be promising.
{"title":"Long-term, bidirectional associations between depressive symptom severity and opioid use among people with HIV: A prospective cohort study","authors":"Alexandria Macmadu , Yu Li , Fiona Bhondoekhan , Chung-Chou H. Chang , Anees Bahji , Stephen Crystal , Kirsha S. Gordon , Robert D. Kerns , Rachel A. Vickers-Smith , E. Jennifer Edelman , Brandon D.L. Marshall","doi":"10.1016/j.abrep.2025.100619","DOIUrl":"10.1016/j.abrep.2025.100619","url":null,"abstract":"<div><h3>Background</h3><div>The bidirectional relationships between opioid use and depressive symptom severity among people living with HIV (PLHIV) are poorly understood. We hypothesized that higher opioid use frequency would be associated with greater subsequent depressive symptom severity and that greater depressive symptom severity would be associated with higher subsequent opioid use frequency.</div></div><div><h3>Methods</h3><div>We analyzed data from the Veterans Aging Cohort Study (VACS) – survey sample, a prospective cohort including PLHIV receiving care at 8 US Veterans Health Administration sites. From 2002 to 2018, we assessed past year opioid use frequency based on self-reported heroin and/or prescription opioid use at study entry and follow-up, as well as depressive symptom severity. Time-lagged, generalized estimating equation models were used to construct estimates of the association between opioid use frequency and subsequent depressive symptom severity, and vice versa, adjusting for key sociodemographic and clinical characteristics.</div></div><div><h3>Results</h3><div>In final adjusted models that included 2033 PLHIV (98 % male), subsequent depressive symptom severity was greater (adjusted odds ratio [aOR] = 1.44, 95 % CI: 1.22,1.70) for those who used opioids at least monthly compared to those who never used, and the association between these variables appeared to follow a dose–response pattern. Similarly, subsequent opioid use frequency was higher (aOR = 1.38, 95 % CI: 1.17,1.62) for those with moderate depressive symptom severity compared to those with none.</div></div><div><h3>Conclusions</h3><div>Enhanced access to screening for substance use disorders, harm reduction services, and medications for opioid use disorder may be warranted in settings that serve veteran PLHIV; strategies expanding access to mental health services may also be promising.</div></div>","PeriodicalId":38040,"journal":{"name":"Addictive Behaviors Reports","volume":"22 ","pages":"Article 100619"},"PeriodicalIF":0.0,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144255478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-29DOI: 10.1016/j.abrep.2025.100616
Jessica P. Orea, Haylee K. DeLuca Bishop, Kim Pulvers
Background
Young adults have the highest rates of Cannabis Use Disorder (CUD) among all age groups. One important yet understudied behavioral factor linked with CUD is Distress Tolerance (DT), and it is unknown whether this association varies as a function of race/ethnicity, despite health disparities. This study tests the hypothesis that the association between DT and CUD symptoms will be stronger among young adults who identify as non-Hispanic Black or Hispanic (under-represented minoritized; URM) and that cannabis coping motives will mediate this association.
Method
Participants with past 30 day cannabis use (N = 451; M = 21.3 years; 54.8 % female; 33.0 % Hispanic; 35.7 % non-Hispanic Black) completed a cross-sectional survey administered through an online panel in 2021, which included measures of Distress Tolerance, Cannabis Coping Motives, and CUD symptoms. Moderation, mediation, and moderated mediation with covariates age, gender, education, income, and cannabis state legality were tested.
Results
Greater distress intolerance was associated with higher CUD symptoms (b = 1.85, p = 0.000) and the effect was stronger for URM than NHW individuals (b = -2.43, p = 0.002).
Cannabis motives mediated the association between distress intolerance and CUD symptoms (indirect effect: b = 1.069, SE = 0.222, 95 % CI(b) = [.662, 1.520]). Moderated mediation was not present, indicating that the link between DT and CUD symptoms by coping motives did not vary by race/ethnicity (index = 0.011, SE = 0.491, 95 % CI(b) = [-0.916, 1.033]).
Conclusion
Developing DT may be a valuable approach for preventing and treating CUD, particularly among young adults from underrepresented backgrounds.
{"title":"Association between distress tolerance and cannabis use disorder symptoms is stronger among U.S. young adults who identify as Hispanic and non-Hispanic Black","authors":"Jessica P. Orea, Haylee K. DeLuca Bishop, Kim Pulvers","doi":"10.1016/j.abrep.2025.100616","DOIUrl":"10.1016/j.abrep.2025.100616","url":null,"abstract":"<div><h3>Background</h3><div>Young adults have the highest rates of Cannabis Use Disorder (CUD) among all age groups. One important yet understudied behavioral factor linked with CUD is Distress Tolerance (DT), and it is unknown whether this association varies as a function of race/ethnicity, despite health disparities. This study tests the hypothesis that the association between DT and CUD symptoms will be stronger among young adults who identify as non-Hispanic Black or Hispanic (under-represented minoritized; URM) and that cannabis coping motives will mediate this association.</div></div><div><h3>Method</h3><div>Participants with past 30 day cannabis use (<em>N</em> = 451; <em>M</em> = 21.3 years; 54.8 % female; 33.0 % Hispanic; 35.7 % non-Hispanic Black) completed a cross-sectional survey administered through an online panel in 2021, which included measures of Distress Tolerance, Cannabis Coping Motives, and CUD symptoms. Moderation, mediation, and moderated mediation with covariates age, gender, education, income, and cannabis state legality were tested.</div></div><div><h3>Results</h3><div>Greater distress intolerance was associated with higher CUD symptoms (<em>b</em> = 1.85, <em>p</em> = 0.000) and the effect was stronger for URM than NHW individuals (<em>b</em> = -2.43, <em>p</em> = 0.002).</div><div>Cannabis motives mediated the association between distress intolerance and CUD symptoms (indirect effect: <em>b</em> = 1.069, <em>SE</em> = 0.222, 95 % CI(<em>b</em>) = [.662, 1.520]). Moderated mediation was not present, indicating that the link between DT and CUD symptoms by coping motives did not vary by race/ethnicity (index = 0.011, <em>SE</em> = 0.491, 95 % CI(<em>b</em>) = [-0.916, 1.033]).</div></div><div><h3>Conclusion</h3><div>Developing DT may be a valuable approach for preventing and treating CUD, particularly among young adults from underrepresented backgrounds.</div></div>","PeriodicalId":38040,"journal":{"name":"Addictive Behaviors Reports","volume":"22 ","pages":"Article 100616"},"PeriodicalIF":0.0,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144194869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-24DOI: 10.1016/j.abrep.2025.100615
Jacob Paredes, Ashish Sandhu, Shutong Huo, David S. Timberlake
Background
Most published studies aimed at curtailing the morbidity and mortality associated with the current U.S. opioid epidemic have focused on unintentional exposure to fentanyl through heroin, cocaine, and other substances. Yet, there is mounting evidence that the intentional use of fentanyl is a key contributor to the current epidemic. In this mini-review we will discuss the harm reduction methods employed by people who intentionally use fentanyl (PWIUF) from a handful of articles found through PubMed that included PWIUF that were published between January 2013 to January 2024.
Results
The perceived harm reduction strategies included co-use of stimulants, dose reduction, buying from a trusted dealer, drug checking, conducting a test shot, carrying naloxone, using fentanyl with others, and switching from injection to another route of administration (e.g., smoking). Some of these harm reduction strategies are frequently used by persons who inject heroin but future research on the efficacy of these harm reduction strategies for fentanyl use is warranted. It is important to note that co-use of stimulants has been associated with an increase in overdose.
Conclusion
Future research is needed to understand intentional fentanyl use, perceived harm reduction strategies and the efficacy of these strategies with the advent of stronger opioids. Future research about PWIUF should consider novel study designs such as the ecological momentary assessment for more granular observation of the use of harm reduction strategies.
{"title":"Mini-review: Harm reduction strategies among people who intentionally use fentanyl","authors":"Jacob Paredes, Ashish Sandhu, Shutong Huo, David S. Timberlake","doi":"10.1016/j.abrep.2025.100615","DOIUrl":"10.1016/j.abrep.2025.100615","url":null,"abstract":"<div><h3>Background</h3><div>Most published studies aimed at curtailing the morbidity and mortality associated with the current U.S. opioid epidemic have focused on unintentional exposure to fentanyl through heroin, cocaine, and other substances. Yet, there is mounting evidence that the intentional use of fentanyl is a key contributor to the current epidemic. In this mini-review we will discuss the harm reduction methods employed by people who intentionally use fentanyl (PWIUF) from a handful of articles found through PubMed that included PWIUF that were published between January 2013 to January 2024.</div></div><div><h3>Results</h3><div>The perceived harm reduction strategies included co-use of stimulants, dose reduction, buying from a trusted dealer, drug checking, conducting a test shot, carrying naloxone, using fentanyl with others, and switching from injection to another route of administration (e.g., smoking). Some of these harm reduction strategies are frequently used by persons who inject heroin but future research on the efficacy of these harm reduction strategies for fentanyl use is warranted. It is important to note that co-use of stimulants has been associated with an increase in overdose.</div></div><div><h3>Conclusion</h3><div>Future research is needed to understand intentional fentanyl use, perceived harm reduction strategies and the efficacy of these strategies with the advent of stronger opioids. Future research about PWIUF should consider novel study designs such as the ecological momentary assessment for more granular observation of the use of harm reduction strategies.</div></div>","PeriodicalId":38040,"journal":{"name":"Addictive Behaviors Reports","volume":"21 ","pages":"Article 100615"},"PeriodicalIF":0.0,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-08DOI: 10.1016/j.abrep.2025.100613
Christian Montag , Jon D. Elhai
In societies around the world, the impact of artificial intelligence (AI) is being fiercely discussed. It is difficult to grasp AI’s influence, because AI represents a general-purpose technology, which can be applied in different settings. One product in which AI plays a pivotal role is social media. In this context, for instance, AI is used to provide people with personalized newsfeeds to prolong time spent online, which might result in addictive-like behavior. Many factors such as sociodemographic variables, history of psychopathology and personality traits have been revealed as risk factors for developing problematic social media use patterns. Yet, to our knowledge attitudes toward AI have not been examined in association with problematic social media use. In a sample of n = 956 social media users, we observed that positive AI attitudes were linked to overuse of social media as assessed with an addiction framework. The effect size of this association was stronger for males than females. Further we observed that this association was mediated by time spent on social media. The present study shows that positive AI attitudes – although well-known to be positive regarding embracing new technologies – might come with risks for developing addictive patterns of technology use, such as social media.
{"title":"The darker side of positive AI attitudes: Investigating associations with (problematic) social media use","authors":"Christian Montag , Jon D. Elhai","doi":"10.1016/j.abrep.2025.100613","DOIUrl":"10.1016/j.abrep.2025.100613","url":null,"abstract":"<div><div>In societies around the world, the impact of artificial intelligence (AI) is being fiercely discussed. It is difficult to grasp AI’s influence, because AI represents a general-purpose technology, which can be applied in different settings. One product in which AI plays a pivotal role is social media. In this context, for instance, AI is used to provide people with personalized newsfeeds to prolong time spent online, which might result in addictive-like behavior. Many factors such as sociodemographic variables, history of psychopathology and personality traits have been revealed as risk factors for developing problematic social media use patterns. Yet, to our knowledge attitudes toward AI have not been examined in association with problematic social media use. In a sample of n = 956 social media users, we observed that positive AI attitudes were linked to overuse of social media as assessed with an addiction framework. The effect size of this association was stronger for males than females. Further we observed that this association was mediated by time spent on social media. The present study shows that positive AI attitudes – although well-known to be positive regarding embracing new technologies – might come with risks for developing addictive patterns of technology use, such as social media.</div></div>","PeriodicalId":38040,"journal":{"name":"Addictive Behaviors Reports","volume":"22 ","pages":"Article 100613"},"PeriodicalIF":0.0,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144190188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-08DOI: 10.1016/j.abrep.2025.100614
Ali Salmani , Sajjad Basharpoor , Zahra Vaziri , Mohammad Ali Salehinejad
Background
Individuals with substance use disorder (iSUD) often show diminished motivation toward treatment-seeking and adherence, resulting in a higher relapse rate, especially during the abstinence phase. A key cognitive correlate of substance use and treatment-seeking behavior is the ability to regulate emotion. While transcranial direct current stimulation (tDCS) shows potential for treating SUD, most studies have focused on craving or cognitive deficits. This randomized, placebo-controlled study examines the effects of 15 daily sessions of prefrontal tDCS on treatment motivation and cognitive emotion regulation in iSUD during the abstinence phase.
Methods
Thirty-two young male iSUDs (mean age= 22.80±1.92) were randomly assigned to the experimental (n=16) or placebo (n=16) groups. The experimental group underwent 15 sessions of anodal left and cathodal right dlPFC stimulation (2 mA, 20 min), while the placebo group received sham stimulation over the same period. Assessments of readiness, eagerness, motivation for treatment, and cognitive emotion regulation were conducted before and after the intervention.
Results
The active repeated prefrontal tDCS significantly boosted motivation for change and treatment in iSUD in comparison to sham tDCS. This intervention specifically improved participants’ recognition of issues related to their substance use and reduced ambivalence about it. Additionally, active prefrontal tDCS enhanced adaptive cognitive emotion regulation while reducing maladaptive cognitive emotion regulation strategies in iSUD.
Conclusions
Repeated prefrontal tDCS can help iSUD during the abstinence phase to improve adaptive emotion regulation strategies, thereby boosting motivation for treatment seeking. Up and downregulation of left and right dlPFCs is a promising approach for cognitively and motivationally preparing iSUD for treatment-seeking.
{"title":"Repeated prefrontal tDCS improves cognitive emotion regulation and readiness for treatment in substance use disorder: A randomized sham-controlled study","authors":"Ali Salmani , Sajjad Basharpoor , Zahra Vaziri , Mohammad Ali Salehinejad","doi":"10.1016/j.abrep.2025.100614","DOIUrl":"10.1016/j.abrep.2025.100614","url":null,"abstract":"<div><h3>Background</h3><div>Individuals with substance use disorder (iSUD) often show diminished motivation toward treatment-seeking and adherence, resulting in a higher relapse rate, especially during the abstinence phase. A key cognitive correlate of substance use and treatment-seeking behavior is the ability to regulate emotion. While transcranial direct current stimulation (tDCS) shows potential for treating SUD, most studies have focused on craving or cognitive deficits. This randomized, placebo-controlled study examines the effects of 15 daily sessions of prefrontal tDCS on treatment motivation and cognitive emotion regulation in iSUD during the abstinence phase.</div></div><div><h3>Methods</h3><div>Thirty-two young male iSUDs (mean age= 22.80±1.92) were randomly assigned to the experimental (n=16) or placebo (n=16) groups. The experimental group underwent 15 sessions of anodal left and cathodal right dlPFC stimulation (2 mA, 20 min), while the placebo group received sham stimulation over the same period. Assessments of readiness, eagerness, motivation for treatment, and cognitive emotion regulation were conducted before and after the intervention.</div></div><div><h3>Results</h3><div>The active repeated prefrontal tDCS significantly boosted motivation for change and treatment in iSUD in comparison to sham tDCS. This intervention specifically improved participants’ recognition of issues related to their substance use and reduced ambivalence about it. Additionally, active prefrontal tDCS enhanced adaptive cognitive emotion regulation while reducing maladaptive cognitive emotion regulation strategies in iSUD.</div></div><div><h3>Conclusions</h3><div>Repeated prefrontal tDCS can help iSUD during the abstinence phase to improve adaptive emotion regulation strategies, thereby boosting motivation for treatment seeking. Up and downregulation of left and right dlPFCs is a promising approach for cognitively and motivationally preparing iSUD for treatment-seeking.</div></div>","PeriodicalId":38040,"journal":{"name":"Addictive Behaviors Reports","volume":"21 ","pages":"Article 100614"},"PeriodicalIF":0.0,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143936997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-17DOI: 10.1016/j.abrep.2025.100610
Jannis Engel , Shane W. Kraus , Li Yan McCurdy , Marc N. Potenza
This article proposes minimum requirements for reporting efficacy in treatment studies of compulsive sexual behavior (CSB). CSB disorder (CSBD) is a condition whose diagnostic criteria were only recently defined by the World Health Organization. Multiple primary and secondary outcomes have been used in treatment trials of CSB, and possible neuropsychological measures have been considered. We suggest including clinical interviews, specifying the nature of the problem behavior and ensuring that the concerns are not entirely related to distress linked to moral judgments or paraphilic interests exclusively. The minimum requirements of reporting the efficacy of behavioral and pharmaceutical treatment outcome studies proposed are measures of: CSB symptom severity – problems in personal health, relationships, work and finance; these measures may be complemented by additional measures of quality of life or sexual health; behavioral engagement in CSB − frequency (in days per week) of CSB, including time spent thinking about or engaged in the pursuit of CSB; change processes – assessing mechanisms of change hypothesized. There are currently no objective (i.e., neuropsychological) measures that can provide a valid picture of the success of therapies. However, promising areas in the brain which reflect treatment changes include prefrontal areas and the reward system. We believe that the guidelines presented should promote harmonized clinical research involving the treatment of CSB and CSBD.
{"title":"Recommendations for Diagnosing and Quantifying treatment outcomes in clinical trials of compulsive sexual behavior disorder","authors":"Jannis Engel , Shane W. Kraus , Li Yan McCurdy , Marc N. Potenza","doi":"10.1016/j.abrep.2025.100610","DOIUrl":"10.1016/j.abrep.2025.100610","url":null,"abstract":"<div><div>This article proposes minimum requirements for reporting efficacy in treatment studies of compulsive sexual behavior (CSB). CSB disorder (CSBD) is a condition whose diagnostic criteria were only recently defined by the World Health Organization. Multiple primary and secondary outcomes have been used in treatment trials of CSB, and possible neuropsychological measures have been considered. We suggest including clinical interviews, specifying the nature of the problem behavior and ensuring that the concerns are not entirely related to distress linked to moral judgments or paraphilic interests exclusively. The minimum requirements of reporting the efficacy of behavioral and pharmaceutical treatment outcome studies proposed are measures of: <em>CSB symptom severity</em> – problems in personal health, relationships, work and finance; these measures may be complemented by additional measures of quality of life or sexual health; <em>behavioral engagement in CSB −</em> frequency (in days per week) of CSB, including time spent thinking about or engaged in the pursuit of CSB<em>; change processes</em> – assessing mechanisms of change hypothesized. There are currently no objective (i.e., neuropsychological) measures that can provide a valid picture of the success of therapies. However, promising areas in the brain which reflect treatment changes include prefrontal areas and the reward system. We believe that the guidelines presented should promote harmonized clinical research involving the treatment of CSB and CSBD.</div></div>","PeriodicalId":38040,"journal":{"name":"Addictive Behaviors Reports","volume":"21 ","pages":"Article 100610"},"PeriodicalIF":0.0,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143868899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}